Cargando…

Regulation of hBD-2, hBD-3, hCAP18/LL37, and Proinflammatory Cytokine Secretion by Human Milk Oligosaccharides in an Organotypic Oral Mucosal Model

Human milk oligosaccharides (HMOs), the third largest solid fraction in human milk, can modulate inflammation through Toll-like receptor signaling, but little is known about their immunomodulatory potential in the oral cavity. In this study, we determined whether the HMOs 2′-fucosyllactose (2′-FL) a...

Descripción completa

Detalles Bibliográficos
Autores principales: Gürsoy, Ulvi K., Salli, Krista, Söderling, Eva, Gürsoy, Mervi, Hirvonen, Johanna, Ouwehand, Arthur C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8231254/
https://www.ncbi.nlm.nih.gov/pubmed/34208335
http://dx.doi.org/10.3390/pathogens10060739
_version_ 1783713388960940032
author Gürsoy, Ulvi K.
Salli, Krista
Söderling, Eva
Gürsoy, Mervi
Hirvonen, Johanna
Ouwehand, Arthur C.
author_facet Gürsoy, Ulvi K.
Salli, Krista
Söderling, Eva
Gürsoy, Mervi
Hirvonen, Johanna
Ouwehand, Arthur C.
author_sort Gürsoy, Ulvi K.
collection PubMed
description Human milk oligosaccharides (HMOs), the third largest solid fraction in human milk, can modulate inflammation through Toll-like receptor signaling, but little is known about their immunomodulatory potential in the oral cavity. In this study, we determined whether the HMOs 2′-fucosyllactose (2′-FL) and 3-fucosyllactose (3-FL) regulate human-beta defensin (hBD)-2 and -3, cathelicidin (hCAP18/LL-37), and cytokine responses in human gingival cells using a three-dimensional oral mucosal culture model. The model was incubated with 0.1% or 1% 2′-FL and 3-FL, alone and in combination, for 5 or 24 h, and hBD-2, hBD-3, and hCAP18/LL-37 were analyzed by immunohistochemistry. The expression profiles of interleukin (IL)-1, IL-1RA, IL-8, and monocyte chemoattractant protein (MCP)-1 were determined by LUMINEX immunoassay. The combination of 1% 2′-FL and 1% 3-FL, and 1% 3-FL alone, for 24 h upregulated hBD-2 protein expression significantly (p < 0.001 and p = 0.016, respectively). No changes in the other antimicrobial peptides or proinflammatory cytokines were observed. Thus, 3-FL, alone and in combination with 2′-FL, stimulates oral mucosal secretion of hBD-2, without effecting a proinflammatory response when studied in an oral mucosal culture model.
format Online
Article
Text
id pubmed-8231254
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-82312542021-06-26 Regulation of hBD-2, hBD-3, hCAP18/LL37, and Proinflammatory Cytokine Secretion by Human Milk Oligosaccharides in an Organotypic Oral Mucosal Model Gürsoy, Ulvi K. Salli, Krista Söderling, Eva Gürsoy, Mervi Hirvonen, Johanna Ouwehand, Arthur C. Pathogens Communication Human milk oligosaccharides (HMOs), the third largest solid fraction in human milk, can modulate inflammation through Toll-like receptor signaling, but little is known about their immunomodulatory potential in the oral cavity. In this study, we determined whether the HMOs 2′-fucosyllactose (2′-FL) and 3-fucosyllactose (3-FL) regulate human-beta defensin (hBD)-2 and -3, cathelicidin (hCAP18/LL-37), and cytokine responses in human gingival cells using a three-dimensional oral mucosal culture model. The model was incubated with 0.1% or 1% 2′-FL and 3-FL, alone and in combination, for 5 or 24 h, and hBD-2, hBD-3, and hCAP18/LL-37 were analyzed by immunohistochemistry. The expression profiles of interleukin (IL)-1, IL-1RA, IL-8, and monocyte chemoattractant protein (MCP)-1 were determined by LUMINEX immunoassay. The combination of 1% 2′-FL and 1% 3-FL, and 1% 3-FL alone, for 24 h upregulated hBD-2 protein expression significantly (p < 0.001 and p = 0.016, respectively). No changes in the other antimicrobial peptides or proinflammatory cytokines were observed. Thus, 3-FL, alone and in combination with 2′-FL, stimulates oral mucosal secretion of hBD-2, without effecting a proinflammatory response when studied in an oral mucosal culture model. MDPI 2021-06-11 /pmc/articles/PMC8231254/ /pubmed/34208335 http://dx.doi.org/10.3390/pathogens10060739 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Communication
Gürsoy, Ulvi K.
Salli, Krista
Söderling, Eva
Gürsoy, Mervi
Hirvonen, Johanna
Ouwehand, Arthur C.
Regulation of hBD-2, hBD-3, hCAP18/LL37, and Proinflammatory Cytokine Secretion by Human Milk Oligosaccharides in an Organotypic Oral Mucosal Model
title Regulation of hBD-2, hBD-3, hCAP18/LL37, and Proinflammatory Cytokine Secretion by Human Milk Oligosaccharides in an Organotypic Oral Mucosal Model
title_full Regulation of hBD-2, hBD-3, hCAP18/LL37, and Proinflammatory Cytokine Secretion by Human Milk Oligosaccharides in an Organotypic Oral Mucosal Model
title_fullStr Regulation of hBD-2, hBD-3, hCAP18/LL37, and Proinflammatory Cytokine Secretion by Human Milk Oligosaccharides in an Organotypic Oral Mucosal Model
title_full_unstemmed Regulation of hBD-2, hBD-3, hCAP18/LL37, and Proinflammatory Cytokine Secretion by Human Milk Oligosaccharides in an Organotypic Oral Mucosal Model
title_short Regulation of hBD-2, hBD-3, hCAP18/LL37, and Proinflammatory Cytokine Secretion by Human Milk Oligosaccharides in an Organotypic Oral Mucosal Model
title_sort regulation of hbd-2, hbd-3, hcap18/ll37, and proinflammatory cytokine secretion by human milk oligosaccharides in an organotypic oral mucosal model
topic Communication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8231254/
https://www.ncbi.nlm.nih.gov/pubmed/34208335
http://dx.doi.org/10.3390/pathogens10060739
work_keys_str_mv AT gursoyulvik regulationofhbd2hbd3hcap18ll37andproinflammatorycytokinesecretionbyhumanmilkoligosaccharidesinanorganotypicoralmucosalmodel
AT sallikrista regulationofhbd2hbd3hcap18ll37andproinflammatorycytokinesecretionbyhumanmilkoligosaccharidesinanorganotypicoralmucosalmodel
AT soderlingeva regulationofhbd2hbd3hcap18ll37andproinflammatorycytokinesecretionbyhumanmilkoligosaccharidesinanorganotypicoralmucosalmodel
AT gursoymervi regulationofhbd2hbd3hcap18ll37andproinflammatorycytokinesecretionbyhumanmilkoligosaccharidesinanorganotypicoralmucosalmodel
AT hirvonenjohanna regulationofhbd2hbd3hcap18ll37andproinflammatorycytokinesecretionbyhumanmilkoligosaccharidesinanorganotypicoralmucosalmodel
AT ouwehandarthurc regulationofhbd2hbd3hcap18ll37andproinflammatorycytokinesecretionbyhumanmilkoligosaccharidesinanorganotypicoralmucosalmodel